Description General description Glipizide is an oral antidiabetic drug that belongs to the class of second-generation sulfonylureas. It is used in the treatment of type 2 diabetes mellitus. It exerts its action by lowering the blood glucose levels via stimulation of insulin release from the β-cells of the pancreas.[1] Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Application Glipizide Related Compound A may be used as a pharmaceutical reference standard for the determination of the analyte in bulk drug and pharmaceutical formulations by high performance liquid chromatography.[2][3] These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. Analysis Note These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. Other Notes This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. Footnote To see an example of a Certificate of Analysis for this material enter LRAA8813 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.